BILL ANALYSIS

HR9552

NEUTRAL

To amend the Countering America's Adversaries Through Sanctions Act to expand review by Congress of actions relating to sanctions imposed with respect to the Russian Federation.

HR9552 (To amend the Countering America's Adversaries Through Sanctions Act to expand review by Congress of actions relating to sanctions imposed with respect to the Russian Federation.) has been assessed with a neutral outlook for investors. The primary sectors impacted are Finance. View the full bill text on Congress.gov.

neutral

Market Sentiment

4/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR 9552 is purely procedural — no new sanctions, no spending, no contracts.

Five finance tickers are neutral: no revenue impact, compliance status quo.

Bill is early-stage with one sponsor, six committees, and no companion — low probability of passage.

How HR9552 Affects the Market

No market implications. This bill does not change any company's revenue, costs, or competitive position. The finance sector should not react. There is no real market data provided, but the legislative structure itself confirms zero economic impact.

Bill Details

Metric	Value
Bill Number	HR9552
Market Sentiment	neutral
Event Date	June 30, 2026
Affected Sectors	Finance
Source	View on Congress.gov →

Summary

HR 9552 is a procedural bill expanding Congressional review of Russia sanctions relief actions. It does not impose new sanctions, authorize funding, or change the current sanctions regime. For financial institutions with Russia exposure, the bill maintains the status quo — no catalyst for change. Impact is minimal and neutral for the sector.

Full AI Market Analysis

What happened: Representative Keating introduced HR 9552 on June 30, 2026. The bill amends the Countering America's Adversaries Through Sanctions Act (CAATSA) to expand Congressional review of executive actions related to Russia sanctions. It was referred to six committees (Foreign Affairs, Judiciary, Financial Services, Oversight, Ways and Means, Rules) — an unusually broad referral indicating the Speaker plans to determine jurisdiction later, a sign of low legislative prioritization. The money trail: The bill contains zero appropriations or authorizations for spending. It is a procedural measure that changes the balance of power between Congress and the executive on sanctions relief. No federal dollars are at stake, and no companies receive direct funding, tax credits, or procurement benefits. No convergence signals exist in the enrichment data. This bill is isolated from other legislative activity. The structural impact: For financial institutions that have maintained Russia sanctions compliance programs (OFAC screening, legal review, correspondent banking restrictions), this bill simply codifies the existing Congressional oversight trend. Since 2022, Congress has already been heavily scrutinizing sanctions relief. The bill makes it harder for any future administration to lift sanctions without bipartisan Congressional consent. However, given the current geopolitical environment, no major sanctions relief on Russia is imminent regardless of this bill. Therefore, the market impact is effectively zero. Timeline: The bill is at the earliest procedural stage — referred to committee. It has only one cosponsor and no Senate companion. Given the 119th Congress is already halfway through its second session (2025–2027), this bill is unlikely to advance without significant bipartisan leadership support. Even if passed, the market impact remains near zero.